Latest Tumors Stories
MGH study identifies components responsible for therapy-blocking solid stress, suggests therapeutic strategies It's a high-pressure environment within solid tumors. Abnormal blood and lymphatic vessels cause fluids to accumulate, and the uncontrolled proliferation of cancer cells within limited space leads to the buildup of what is called solid stress. Both types of pressure can interfere with the effectiveness of anticancer treatments, but while strategies have been developed that reduce...
BETHESDA, Md., Sept. 20, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that it is in late stage discussions with medical centers in the U.S. and Europe to proceed with a Phase I/II clinical trial with the Company's third major product line, DCVax(®)-Direct, for all types of solid tumor cancers (i.e., cancers in any tissues). The Company previously received...
LONDON, Sept. 19, 2012 /PRNewswire/ -- The first animal feeding trial studying the lifetime effects of exposure to Roundup tolerant GM maize, and Roundup, the world's best-selling weedkiller, shows that levels currently considered safe can cause tumors and multiple organ damage and lead to premature death in laboratory rats, according to research published online today by the scientific journal Food and Chemical Toxicology. Researchers found that rats fed on a diet containing NK603...
BERLIN, Sept. 17, 2012 /PRNewswire/ -- Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, presented Phase 2 clinical data of JX-594 delivered first intravenously and subsequently through intra-tumoral route demonstrating safety as well as disease control and tumor responses in patients with hepatocellular carcinoma (liver cancer, HCC). The data were presented in an...
AMSTERDAM and FARNHAM, England, September 14, 2012 /PRNewswire/ -- Launch of collaboration marked with development of new treatment protocol for trans-arterial embolization in hypervascular tumors Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Biocompatibles, a BTG international group company, announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularized tumors today at the...
April Flowers for redOrbit.com - Your Universe Online Two recent studies have shown real progress in killing cancer cells in dogs. The first study, from the University of Illinois at Urbana-Champaign, reports that myxoma, a pox virus that affects rabbits but not humans, dogs or other vertebrates studied so far, infects several different types of canine cancer cells in cell culture while sparing healthy cells. The study adds to the evidence that viruses or modified viruses will emerge as...
Lee Rannals for redOrbit.com – Your Universe Online Boosting the activity of a particular enzyme can help block tumors from growing, according to research published in Nature Chemical Biology. Cancer cells use up most of their energy by reproducing themselves, but in order to do this they must produce new cellular building blocks like DNA, carbohydrates and lipids. Biologists found that jacking up the activity of the enzyme pyruvate kinase can disrupt the production of tumors...
Caltech chemists determine 1 way tumors meet their growing needs Behaving something like ravenous monsters, tumors need plentiful supplies of cellular building blocks such as amino acids and nucleotides in order to keep growing at a rapid pace and survive under harsh conditions. How such tumors meet these burgeoning demands has not been fully understood. Now chemists at the California Institute of Technology (Caltech) have shown for the first time that a specific sugar, known as GlcNAc...
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland. The extract, known as epigallocatechin gallate, has been known to have preventative anti-cancer properties but fails to reach tumors when delivered by conventional intravenous administration. However, in initial laboratory tests at the Universities of Strathclyde and Glasgow, researchers used an approach which...
An inexpensive antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy for cancer. Scientists in the College of Natural Sciences at The University of Texas at Austin made this discovery by exploiting the evolutionary relatedness of yeast, frogs, mice and humans. Thiabendazole is an FDA-approved, generic drug taken orally that has been in clinical use for 40 years as an antifungal. It is not currently used for cancer therapy. Hye Ji Cha, Edward Marcotte,...
